These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29478010)

  • 21. The prevalence of congenital anomalies in Europe.
    Dolk H; Loane M; Garne E
    Adv Exp Med Biol; 2010; 686():349-64. PubMed ID: 20824455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital Malformation Risk According to Hemoglobin A1c Values in a Contemporary Cohort with Pregestational Diabetes.
    Martin RB; Duryea EL; Ambia A; Ragsdale A; Mcintire D; Wells CE; Spong CY; Dashe JS; Nelson DB
    Am J Perinatol; 2021 Oct; 38(12):1217-1222. PubMed ID: 34087946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exposure of Pregnancy to Pregestational Diabetes, Gestational Diabetes, and Antidiabetic Medications With Especial Focus on Major Congenital and Cardiac Malformations in Offspring.
    Andrade C
    J Clin Psychiatry; 2024 Mar; 85(1):. PubMed ID: 39324842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza and congenital anomalies: a systematic review and meta-analysis.
    Luteijn JM; Brown MJ; Dolk H
    Hum Reprod; 2014 Apr; 29(4):809-23. PubMed ID: 24365800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetal Exposure to Montelukast and Congenital Anomalies: A Population Based Study in Denmark.
    Cavero-Carbonell C; Vinkel-Hansen A; Rabanque-Hernández MJ; Martos C; Garne E
    Birth Defects Res; 2017 Apr; 109(6):452-459. PubMed ID: 28398707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety of sumatriptan and naratriptan in pregnancy: what have we learned?
    Cunnington M; Ephross S; Churchill P
    Headache; 2009; 49(10):1414-22. PubMed ID: 19804390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
    Ban L; Tata LJ; Fiaschi L; Card T
    Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal exposure to ambient air pollutants and risk of congenital anomalies.
    Rankin J; Chadwick T; Natarajan M; Howel D; Pearce MS; Pless-Mulloli T
    Environ Res; 2009 Feb; 109(2):181-7. PubMed ID: 19135190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry.
    Hellwig K; Geissbuehler Y; Sabidó M; Popescu C; Adamo A; Klinger J; Ornoy A; Huppke P;
    J Neurol; 2020 Jun; 267(6):1715-1723. PubMed ID: 32100126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
    Graner S; Svensson T; Beau AB; Damase-Michel C; Engeland A; Furu K; Hviid A; Håberg SE; Mølgaard-Nielsen D; Pasternak B; Kieler H
    BMJ; 2017 Feb; 356():j629. PubMed ID: 28246106
    [No Abstract]   [Full Text] [Related]  

  • 33. Newer-generation antiepileptic drugs and the risk of major birth defects.
    Mølgaard-Nielsen D; Hviid A
    JAMA; 2011 May; 305(19):1996-2002. PubMed ID: 21586715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of non-insulin glucose-lowering drugs in pregnant women with pre-gestational diabetes: A cohort study.
    Cea-Soriano L; García-Rodríguez LA; Brodovicz KG; Masso Gonzalez E; Bartels DB; Hernández-Díaz S
    Diabetes Obes Metab; 2018 Jul; 20(7):1642-1651. PubMed ID: 29498473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study.
    Garne E; Hansen AV; Morris J; Zaupper L; Addor MC; Barisic I; Gatt M; Lelong N; Klungsøyr K; O'Mahony M; Nelen V; Neville AJ; Pierini A; Tucker D; de Walle H; Wiesel A; Loane M; Dolk H
    J Allergy Clin Immunol; 2015 Dec; 136(6):1496-1502.e7. PubMed ID: 26220526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?
    Dolk H; Jentink J; Loane M; Morris J; de Jong-van den Berg LT;
    Neurology; 2008 Sep; 71(10):714-22. PubMed ID: 18650491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents.
    Ekpebegh CO; Coetzee EJ; van der Merwe L; Levitt NS
    Diabet Med; 2007 Mar; 24(3):253-8. PubMed ID: 17305787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating Global Burden of Disease due to congenital anomaly: an analysis of European data.
    Boyle B; Addor MC; Arriola L; Barisic I; Bianchi F; Csáky-Szunyogh M; de Walle HEK; Dias CM; Draper E; Gatt M; Garne E; Haeusler M; Källén K; Latos-Bielenska A; McDonnell B; Mullaney C; Nelen V; Neville AJ; O'Mahony M; Queisser-Wahrendorf A; Randrianaivo H; Rankin J; Rissmann A; Ritvanen A; Rounding C; Tucker D; Verellen-Dumoulin C; Wellesley D; Wreyford B; Zymak-Zakutnia N; Dolk H
    Arch Dis Child Fetal Neonatal Ed; 2018 Jan; 103(1):F22-F28. PubMed ID: 28667189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study.
    Diav-Citrin O; Steinmetz-Shoob S; Shechtman S; Ornoy A
    Reprod Toxicol; 2018 Sep; 80():85-91. PubMed ID: 29857030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.